The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Preoperative F-18 Fluorodeoxyglucose-Positron Emission Tomography Maximal Standardized Uptake Value Predicts Survival After Lung Cancer Resection
Abstract
Purpose: A retrospective review of surgically treated lung cancer patients imaged preoperatively by F-18 fluorodeoxyglucose–positron emission tomography ([18 F]FDG-PET) to determine if the primary tumor standardized uptake value (SUV) predicts survival. Patients and Methods: Non–small-cell lung cancer or carcinoid pT1–4, N0–2, M0 patients treated by R0 surgical resection alone were imaged with computed tomography scan and PET within 90 days before surgery. Prognostic variables were assessed by log-rank test; survival was assessed by the method of Kaplan and Meier. Results: One hundred consecutive patients (48 men, 52 women) were retrospectively reviewed. Median follow-up for surviving patients was 28 months (range, 16 to 81 months). Median maximal SUV (SUV MAX) was 9. The 2-year survival for patients with SUV MAX more than 9 was 68% and for those with SUV MAX less than 9, it was 96% (P < .01, log-rank test). In a multivariate analysis including pathologic tumor size, involved nodes, histology, and SUV MAX, only tumor size (T) more than 3 cm and SUV MAX more than 9 and their interaction were significant predictors of survival (P = .01, 0.02, and < 0.01, respectively). The 3-year survivals for patients with both T less than 3 cm and SUV MAX less than 9 was 97%; for those with T less than 3 cm and SUV MAX more than 9, it was 94%; for those with T more than 3 cm and SUV MAX less than 9, it was 93%; and for those with T more than 3 cm and SUV MAX more than 9, it was 47% (P < .01). Conclusion: In surgically managed lung cancer patients, SUV is a predictor of overall survival after resection. The addition of SUV MAX to pathologic tumor size identifies a subgroup of patients at highest risk for death as a result of recurrent disease after resection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885
Revisions in the International System for Staging Lung Cancer
Mountain, C. F. (1997) · Chest · doi:10.1378/chest.111.6.1710 · Cited by 4,565
Rosell, R., Gomez-Codina, J., Camps, C., Maestre, J., Padille, J., Canto, A., Mate, J. L., Li, S., Roig, J., Olazabal, A., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401203300301 · Cited by 1,261
Roth, J. A., Fossella, F., Komaki, R., Ryan, M. B., Putnam, J. B., Lee, J. S., Dhingra, H., De Caro, L., Chasen, M., McGavran, M., et al. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.9.673 · Cited by 1,111
Vansteenkiste, J. F., Stroobants, S. G., Dupont, P. J., De Leyn, P. R., Verbeken, E. K., Deneffe, G. J., Mortelmans, L. A., & Demedts, M. G. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3201 · Cited by 439
Vesselle, H. J., Schmidt, R. A., Pugsley, J. M., Li, M., Kohlmyer, S. G., Vallires, E., & Wood, D. E. (2000) · PubMed · Cited by 351
Ahuja, V., Coleman, R. E., Herndon, J., & Patz, E. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980901)83:5<918::aid-cncr17>3.0.co;2-y · Cited by 331
Vesselle, H. J., Grierson, J. R., Muzi, M., Pugsley, J. M., Schmidt, R. A., Rabinowitz, P., Peterson, L. M., Vallières, E., & Wood, D. E. (2002) · PubMed · Cited by 300
Reed, C. E., Harpole, D. H., Posther, K. E., Woolson, S. L., Downey, R. J., Meyers, B. F., Heelan, R. T., MacApinlac, H. A., Jung, S.-H., Silvestri, G. A., et al. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2003.07.030 · Cited by 300
Self-citationHigashi, K., Ueda, Y., Arisaka, Y., Sakuma, T., Nambu, Y., Oguchi, M., Seki, H., Taki, S., Tonami, H., & Yamamoto, I. (2002) · PubMed · Cited by 272
Induction chemotherapy before surgery for early-stage lung cancer: A novel approach
Pisters, K. M. W., Ginsberg, R. J., Giroux, D. J., Putnam, J. B., Kris, M. G., Johnson, D. H., Roberts, J. R., Mault, J., Crowley, J. J., & Bunn, P. A. (2000) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(00)70120-6 · Cited by 235
Tumor doubling time and prognostic assessment of patients with primary lung cancer
Usuda, K., Saito, Y., Sagawa, M., Sato, M., Kanma, K., Takahashi, S., Endo, C., Chen, Y., Sakurada, A., & Fujimura, S. (1994) · Cancer · doi:10.1002/1097-0142(19941015)74:8<2239::aid-cncr2820740806>3.0.co;2-p · Cited by 230
Duhaylongsod, F. G., Lowe, V. J., Patz, E. F., Vaughn, A. L., Coleman, R. E., & Wolfe, W. G. (1995) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(05)80018-2 · Cited by 206
[18F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer✩
Dhital, K. K., Saunders, C. A. B., Seed, P. T., O'Doherty, M. J., & Dussek, J. E. (2000) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(00)00535-2 · Cited by 151
Jeong, H. J., Min, J., PARK, J. M., Chung, J., KIM, B. T., Jeong, J. M., Lee, D. S., LEE, M. C., Han, S.-R., & Shim, Y.-M. (2002) · Nuclear Medicine Communications · doi:10.1097/00006231-200209000-00010 · Cited by 146
Arai, T., Kuroishi, T., Saito, Y., 栗田, 雄., Naruke, T., & Kaneko, M. (1994) · Japanese Journal of Clinical Oncology · doi:10.1093/oxfordjournals.jjco.a039706 · Cited by 124
Cited by
Fass, L. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.04.001 · Cited by 822
Concordance probability and discriminatory power in proportional hazards regression
Gönen, M., & Heller, G. (2005) · Biometrika · doi:10.1093/biomet/92.4.965 · Cited by 673
Berghmans, T., Dusart, M., Paesmans, M., Hossein-Foucher, C., Buvat, I., Castaigne, C., Scherpereel, A., Mascaux, C., Moreau, M., Roelandts, M., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31815e6d6b · Cited by 524
Binderup, T., Knigge, U., Loft, A., Federspiel, B., & Kjaer, A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1759 · Cited by 489
Selection of Patients for Resection of Hepatic Colorectal Metastases: Expert Consensus Statement
Charnsangavej, C., Clary, B., Fong, Y., Grothey, A., Pawlik, T. M., & Choti, M. A. (2006) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9023-y · Cited by 354
Metadata
- Authors
- Downey, R. J., Akhurst, T., Gonen, M., Vincent, A., Bains, M. S., Larson, S., & Rusch, V.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-08-15
- Volume
- 22
- Issue
- 16
- Pages
- 3255-3260
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2151547720
- Cited by
- 358
- References
- 16
- FWCI
- 18.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.